Healthcare Sales & Marketing Network News: COX

Searching News Database: COX

HSMN NewsFeed - 13 Feb 2026
InVera Medical Achieves European CE Mark Approval for New Vein Infusion Device
Devices Regulatory

HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Biopharmaceuticals Generics Mergers & Acquisitions

HSMN NewsFeed - 23 Dec 2024
Stuart Therapeutics Announces the Appointment of Two New Board Members
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 2 Dec 2024
Mallinckrodt Completes Divestiture of Therakos(R) Business
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 10 Sep 2024
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.(R) Therapy
Devices Wound Care Product Launch

HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Mar 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(R)
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 19 Jun 2023
Sirnaomics Advances STP705 for Squamous Cell Carcinoma In Situ into Late-Stage Clinical Development
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Aug 2022
Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Mar 2022
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 2 Feb 2022
Bexion Pharmaceuticals Announces Leadership Additions
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2021
Oyster Point Pharma Announces FDA Approval of TYRVAYA(TM) (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 12 Aug 2021
Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR(TM) Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery
Devices FDA

HSMN NewsFeed - 1 Jul 2021
Sirnaomics Secures $105 Million in Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Mar 2021
Zimmer Biomet Expands Role for Ivan Tornos, Appointing Him to New Chief Operating Officer Post
Devices Orthopaedic Personnel

HSMN NewsFeed - 6 Jan 2021
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 21 Oct 2020
SOPHiA GENETICS Raises $110 Million in Oversubscribed New Funding Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Oct 2020
SOPHiA GENETICS Raises $110 Million in Oversubscribed New Funding Round
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 16 Oct 2019
Eyevance Pharmaceuticals Acquires TOBRADEX(R) ST and NATACYN(R)
Biopharmaceuticals Ophthalmology Acquisitions

HSMN NewsFeed - 29 Jul 2019
Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Jun 2019
AbbVie to Acquire Allergan in Transformative Move for Both Companies
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Jun 2019
ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.
Biopharmaceuticals Generics Acquisitions

HSMN NewsFeed - 30 Apr 2019
510(k) Market Clearance for FluChip-8G Influenza A+B Assay
Diagnostics FDA

HSMN NewsFeed - 26 Apr 2019
Aratana Therapeutics to be Acquired by Elanco Animal Health
Biopharmaceuticals Veterinary Mergers & Acquisitions

HSMN NewsFeed - 7 Mar 2019
Ryan J. Dickinson Named Vice President Of Sales And New Business Development For Camber Spine
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 28 Jan 2019
First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Presented at Major Surgical Meeting
Devices Regenerative Medicine

HSMN NewsFeed - 14 Nov 2018
Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality(TM) (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 25 Sep 2018
Dr. Dmitry Samarsky Joins Sirnaomics Senior Management Team as Chief Technology Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Aug 2018
Dthera Sciences Receives FDA Breakthrough Device Designation For Its Alzheimer's Focused Development-Stage Product "DTHR-ALZ"
Devices Neurology FDA

HSMN NewsFeed - 25 Jun 2018
FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea
Devices FDA

HSMN NewsFeed - 20 Apr 2018
SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer & Treasurer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 29 Mar 2018
TAP Blood Collection Device Receives CE Mark
Devices Regulatory

HSMN NewsFeed - 3 Jan 2018
Recro Pharma Announces Key Executive Promotions to the Financial Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Dec 2017
Bausch & Lomb Begins Distribution Of VYZULTA(TM) (latanoprostene bunod ophthalmic solution), 0.024% To U.S. Wholesalers
Biopharmaceuticals Ophthalmology Product Launch

HSMN NewsFeed - 6 Dec 2017
Sirnaomics' Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 28 Nov 2017
GenePOC Launches its GenePOC(TM) CDiff Test in the United States
Diagnostics FDA Product Launch

HSMN NewsFeed - 15 Nov 2017
Noden Pharma Announces FDA Approval of Tekturna(R) (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 17 May 2017
Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 7 Apr 2017
FDA Approves Two Hepatitis C Drugs for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Mar 2017
Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Mar 2017
Recro Pharma Appoints Bryan Reasons to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Mar 2017
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in France
Biopharmaceuticals Product Launch

HSMN NewsFeed - 3 Feb 2017
Amgen Announces Repatha(R) (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 8 Dec 2016
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in the UK
Biopharmaceuticals Product Launch

HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology

HSMN NewsFeed - 10 Aug 2016
Alafair Biosciences Secures $2.0 Million Series A Financing Round
Devices Venture Capital

HSMN NewsFeed - 5 Jul 2016
Recro Pharma Appoints Michael Celano as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Feb 2016
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
Biopharmaceuticals Product Launch

HSMN NewsFeed - 16 Feb 2016
Recro Pharma Appoints Fred Graff as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Dec 2015
Kyras Therapeutics Launches With Versant Ventures Backing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Dec 2015
NuVasive Appoints Jason D. Hanson as Executive Vice President, Strategy, Corporate Development and General Counsel
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 23 Nov 2015
Pfizer and Allergan to Combine
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Oct 2015
Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Oct 2015
Recro Pharma Provides Pipeline Update
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2015
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX(TM) - First Low Dose SoluMatrix(R) Meloxicam for Osteoarthritis Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Oct 2015
Biogen Announces Departure of Tony Kingsley
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Sep 2015
Mylan Commences Offer to Acquire Perrigo
Biopharmaceuticals Generic Mergers & Acquisitions

HSMN NewsFeed - 6 Jul 2015
Strensiq(R) (asfotase alfa) Receives Marketing Approval in Japan for Treatment of Patients with Hypophosphatasia (HPP)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Jan 2015
Euclises Announces Appointment of Bobby Sandage as New CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Oct 2014
QLT Appoints Dr. Geoffrey F. Cox as Interim Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 28 Jul 2014
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Jun 2014
Medtronic to Acquire Covidien for $42.9 billion in Cash and Stock
Devices Mergers & Acquisitions

HSMN NewsFeed - 21 Apr 2014
ClearFlow Inc. Appoints Senior Sales Executive to North America Leadership Position
Devices Personnel

HSMN NewsFeed - 17 Apr 2014
Teva Settles Patent Litigation with Pfizer on Celebrex(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 7 Apr 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreement Under Which Mallinckrodt Will Acquire Questcor For Approximately $5.6 Billion, Creating A Diversified, High-Growth Specialty Pharmaceuticals Company
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Apr 2014
Integra LifeSciences Announces Camino(R) Flex Ventricular Catheter Receives FDA Clearance for Use With MRI Scans
Devices Neurosurgery FDA

HSMN NewsFeed - 19 Mar 2014
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Jan 2014
Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene(TM) AMD test in North America
Diagnostics Ophthalmology Licensing

HSMN NewsFeed - 3 Jan 2014
Iroko’s ZORVOLEX(TM) Now Available
Biopharmaceuticals Product Launch

HSMN NewsFeed - 21 Oct 2013
Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System
Devices Monitoring Neurosurgery Product Launch

HSMN NewsFeed - 9 Oct 2013
USGI Medical Receives FDA Approval to Launch Head-to-Head Pivotal Study to Determine Safety, Effectiveness of Incisionless, Endoscopic Weight Loss Procedure
Devices Surgery FDA

HSMN NewsFeed - 25 Jul 2013
Aerie Pharmaceuticals Names Vicente Anido, Jr., Current Chairman of the Board, as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 29 Apr 2013
Integra LifeSciences Debuts Next-Generation Camino(R) Platform at 2013 American Association of Neurological Surgeons Annual Meeting
Devices Neurosurgery Monitoring Product Launch

HSMN NewsFeed - 11 Mar 2013
Precision Therapeutics Announces Topline Prospective Clinical Data Demonstrating Significant Improvement in Overall Survival and Progression Free Survival in Recurrent Ovarian Cancer using Personalized Chemotherapy Diagnostic ChemoFx(R)
Diagnostics Oncology Personalized Medicine

HSMN NewsFeed - 5 Mar 2013
United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex(R) (celecoxib capsules)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 8 Nov 2012
KCI Sells Therapeutic Support Systems(TM) Business to Getinge AB
Devices Wound Care Acquisitions

HSMN NewsFeed - 15 Aug 2012
KCI Agrees to Divest its Therapeutic Support Systems(TM) Business to Getinge AB
Devices Wound Care Acquisitions

HSMN NewsFeed - 2 Apr 2012
NicOx appoints Philippe Masquida EVP, Managing Director of European Operations ; Next step in the Company's strategy to create an international ophthalmology company
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 29 Mar 2012
Covidien Announces Launch of AccuMesh™ Positioning System
Devices

HSMN NewsFeed - 21 Mar 2012
Jerry St. Peter appointed Executive Vice President and General Manager of NicOx Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jan 2012
Jazz Pharmaceuticals plc Announces New Executive Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Nov 2011
CorMatrix Receives Full IDE Approval for the Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Patients Receiving the CorMatrix(R) ECM(R) for Pericardial Closure
Devices Cardiology

HSMN NewsFeed - 3 Nov 2011
Tangent Medical Closes $4.5 Million Series A Financing
Devices Venture Capital Personnel

HSMN NewsFeed - 2 Jun 2011
Covidien Announces U.S. 510(k) Clearance and European CE Mark Approval of Parietex(TM) Optimized Composite Mesh
Devices Surgery FDA Regulatory

HSMN NewsFeed - 9 May 2011
Alkermes to Merge with Elan Drug Technologies to Create Alkermes plc
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Mar 2011
Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Mar 2011
Covidien Receives FDA Approval for South African-Produced Medical Isotope Based on Low-Enriched Uranium
Devices Radiology FDA

HSMN NewsFeed - 1 Nov 2010
Integra LifeSciences Awarded Three Contracts With The Broadlane Group to Provide Dural Substitute, Neuro Trauma and Hydrocephalus Products
Devices Neurosurgery Group Purchasing

HSMN NewsFeed - 25 Oct 2010
Study Finds Correlation Between Pericardial Reconstruction with CorMatrix ECM(TM) Technology and Reduced Risk of Postoperative Atrial Fibrillation in CABG Patients
Devices Cardiology

HSMN NewsFeed - 28 Sep 2010
Medtronic's Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients
Devices Monitoring Cardiology

HSMN NewsFeed - 22 Sep 2010
Texas Oncology Acquires Hyperthermia System from BSD Medical
Devices Oncology

HSMN NewsFeed - 20 Sep 2010
Athersys Announces Groundbreaking Data Showing Neuroprotective Effects of MultiStem Therapy for Traumatic Brain Injury
Regenerative Medicine Neurology

HSMN NewsFeed - 7 Sep 2010
Pharmaceutical Industry Veteran Dr. Craig Eagle Appointed as an Independent Member to Regenicin Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 22 Jul 2010
FDA provides Complete Response Letter to NicOx's New Drug Application for naproxcinod
Biopharmaceuticals

HSMN NewsFeed - 16 Jun 2010
GTC Biotherapeutics Announces New $7 Million Financing, Company Restructuring and Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jun 2010
Biogen Idec Provides Update on CEO Search and Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2010
Sequent Medical Announces Closing of $15.6 Million Venture Financing
Devices Interventional Venture Capital Personnel

HSMN NewsFeed - 13 May 2010
NicOx provides update on FDA Advisory Committee Meeting for naproxcinod
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Mar 2010
Cardima's Surgical Ablation Probe Receives CE Mark Approval for the Surgical Treatment of Atrial Fibrillation
Devices Cardiology Regulatory

HSMN NewsFeed - 3 Mar 2010
NicOx and Bausch & Lomb Announce Worldwide Licensing Agreement for NCX 116
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 25 Feb 2010
Pharmaceutical Industry Veteran is Appointed CMO at Kinex Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2010
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital

HSMN NewsFeed - 2 Dec 2009
Cardinal Health Names Carrie Cox to Board of Directors
Devices Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Nov 2009
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 26 Oct 2009
New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 26 Oct 2009
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Oct 2009
National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
Devices Neurology

HSMN NewsFeed - 6 Oct 2009
Transdel Pharmaceuticals Announces Positive Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 23 Jul 2009
Allergan Receives FDA Approval for ACUVAIL Ophthalmic Solution for the Treatment of Pain and Inflammation Following Cataract Surgery
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 8 Jul 2009
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 29 Jun 2009
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2009
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 May 2009
UCB receives CHMP positive opinion on bringing Neupro(R) back to all patients in Europe
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 28 Apr 2009
Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Mar 2009
GE Healthcare Announces Data from Phase III Study of AdreView in Heart Failure Patients
Biopharmaceuticals Cardiology Radiology

HSMN NewsFeed - 20 Feb 2009
UCB to divest Equasym(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 6 Feb 2009
ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 20 Jan 2009
ATS Medical Announces Formation of Cryoablation Surgical Advisory Board
Devices Cardiology

HSMN NewsFeed - 24 Nov 2008
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Biopharmaceuticals

HSMN NewsFeed - 30 Oct 2008
TeleHealth Names Matthew K. Barker to Director of Marketing Position
Personnel

HSMN NewsFeed - 13 Oct 2008
USGI Announces Key Management Appointments
Devices Surgery Personnel

HSMN NewsFeed - 2 Oct 2008
ATS Medical Announces US Launch of ATS CryoMaze Surgical Ablation Clamp
Devices Cardiology

HSMN NewsFeed - 15 Sep 2008
NicOx announces second naproxcinod pivotal phase 3 study (302) meets efficacy primary endpoints and supports non-detrimental blood pressure effect
Biopharmaceuticals

HSMN NewsFeed - 15 Sep 2008
Keppra XR(TM) Approved in the U.S.
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 25 Aug 2008
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Aug 2008
St. Jude Medical Announces CE Mark Approval and FDA Clearance for New Family of HIFU Surgical Ablation Products
Devices FDA Cardiology

HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
Biopharmaceuticals

HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 May 2008
Merck Resolves Investigations Under State Consumer Protection Statutes Related to VIOXX
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 May 2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
Devices Interventional Cardiology

HSMN NewsFeed - 1 May 2008
Coversyl(R) Protects Hypertensive Patients Against New-Onset Diabetes
Biopharmaceuticals

HSMN NewsFeed - 30 Apr 2008
ATS Medical Announces First 'Frontiers in Cryoablation' Symposium
Devices Cardiology

HSMN NewsFeed - 25 Apr 2008
Neupro(R) recommended for approval in Europe for Restless Legs Syndrome
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Apr 2008
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2008
Merck Responds to Journal of the American Medical Association Articles
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2008
BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Apr 2008
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
Devices Interventional Cardiology

HSMN NewsFeed - 28 Mar 2008
Barr Announces Reorganization of Senior Management, Business Functions
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2008
Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
Biopharmaceuticals

HSMN NewsFeed - 10 Mar 2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2008
New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
Devices Monitoring

HSMN NewsFeed - 25 Feb 2008
Last Patient Enrolled In ATryn(R) Pivotal Study
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2008
ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
Devices Cardiology

HSMN NewsFeed - 11 Feb 2008
AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy(TM) Bipolar Ablation System to Treat Atrial Fibrillation
Devices Cardiology

HSMN NewsFeed - 7 Feb 2008
Transdel Pharmaceuticals Submits to the FDA the Phase 3 Clinical Study of Ketotransdel(TM) for the Treatment of Acute Pain
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 22 Jan 2008
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jan 2008
Mersana Therapeutics, Inc. Appoints John H. van Duzer, Ph.D., as Vice President of Manufacturing and Pharmaceutical Sciences
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jan 2008
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
Biopharmaceuticals

HSMN NewsFeed - 19 Dec 2007
Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 13 Dec 2007
Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Biopharmaceuticals

HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Advanced-Stage Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Dec 2007
Neupro(R) Filed with the FDA for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Neurology

HSMN NewsFeed - 12 Dec 2007
ATS Medical Appoints James L. Cox, M.D. as Medical Director
Devices Cardiology Personnel

HSMN NewsFeed - 10 Dec 2007
GTC Obtains FDA Orphan Drug Designation For ATryn(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Dec 2007
Mary Ann Gray Elected to GTC Biotherapeutics Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2007
Neupro(R) Filed in Europe for the Treatment of Restless Legs Syndrome
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology

HSMN NewsFeed - 12 Nov 2007
Orexo Acquires Biolipox
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Nov 2007
NicOx' naproxcinod phase 3 results presented at American College of Rheumatology
Biopharmaceuticals

HSMN NewsFeed - 7 Nov 2007
Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 7 Nov 2007
New Clinical Study Shows Limbrel(TM) as Effective as Naproxen for Knee Osteoarthritis
BIopharmaceuticals

HSMN NewsFeed - 1 Nov 2007
Biovail Launches Ralivia(TM) to Canadian Physicians
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 Oct 2007
NicOx opens US headquarters in New Jersey
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Oct 2007
Alpharma Closes Transaction to License U.S. Rights for Prescription Topical NSAID Pain Drug
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 10 Oct 2007
Anesiva Defines Regulatory Pathway for Adlea with FDA
Biopharmaceuticals Surgery

HSMN NewsFeed - 4 Oct 2007
Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
Devices Monitoring

HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Biopharmaceuticals

HSMN NewsFeed - 11 Sep 2007
Integra LifeSciences Announces Launch of the Camino Advanced Monitor, a State of the Art Monitoring System for Traumatic Brain Injury Patients
Devices Monitoring Neurosurgery

HSMN NewsFeed - 10 Sep 2007
Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
Devices Oncology

HSMN NewsFeed - 6 Sep 2007
New Jersey High Court Denies Nationwide Class-Action Status to Insurance Companies Seeking VIOXX(R) Reimbursements
Biopharmaceuticals Litigation

HSMN NewsFeed - 2 Sep 2007
Angiox(R) (Bivalirudin) Alone Reduced Early Bleeding and Resulted in Similar One-Year Mortality Compared to Heparins Plus GP IIb/IIIa Combination Therapy in ACS Patients Undergoing Angioplasty
Biopharmaceuticals Cardiology

HSMN NewsFeed - 14 Aug 2007
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Aug 2007
Cook Medical Announces Breakthrough Device for Diagnosis of Abnormal Uterine Bleeding
Devices

HSMN NewsFeed - 17 Jul 2007
Quidel Corporation Announces Exclusive Licenses to Molecular Antiviral Resistance and Detection Technology for Influenza
Diagnostics Licensing

HSMN NewsFeed - 12 Jul 2007
Labopharm and Paladin Complete Canadian Licensing and Distribution Agreement for Labopharm's Once-Daily Tramadol Product
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 10 Jul 2007
Victory Pharma, Inc. Doubling U.S. Sales Force
Biopharmaceuticals

HSMN NewsFeed - 2 Jul 2007
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jun 2007
Genzyme Files for Approval of Single-Treatment Synvisc-One(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jun 2007
Labopharm's Once-Daily Tramadol Approved for Sale in Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Jun 2007
NicOx Provides an Update on NCX 4016
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Jun 2007
Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA(TM)) Treatment for Patients with Amyloid A (AA) Amyloidosis
Biopharmaceuticals

HSMN NewsFeed - 5 Jun 2007
Encouraging Clinical Activity of GSK's Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2007
ARIAD Presents Additional Efficacy Data on AP23573, Novel mTOR Inhibitor, in Phase 2 Advanced Sarcoma Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 May 2007
Pfizer and Express Scripts Sign Agreement
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 May 2007
Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
Biopharmaceuticals

HSMN NewsFeed - 23 May 2007
New Way to Use High Resolution CT Scan Shows Mechanism of Bronchial Valve Treatment in Patients with Severe Emphysema
Devices

HSMN NewsFeed - 22 May 2007
New Analysis of Data Shows Treatment With Abbott's HUMIRA(R) (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 21 May 2007
Asthmatx Completes Enrollment in Pivotal Study of Bronchial Thermoplasty: Milestone Reached in Advancement of Bronchial Thermoplasty, an Innovative Non-Drug Procedure for Asthma
Devices

HSMN NewsFeed - 15 May 2007
ESTECH COBRA(R) Devices and Patented ''Box Lesion'' Acknowledged as Key Elements in Successful Cardiac Ablation at Recent American Association for Thoracic Surgery 87th Annual Meeting
Devices Cardiology

HSMN NewsFeed - 4 May 2007
ATS 3f Aortic Bioprosthesis Offers Unique Approach to Enhanced Durability
Devices Cardiology

HSMN NewsFeed - 30 Apr 2007
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Apr 2007
Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Apr 2007
Valeant Pharmaceuticals Re-Signs Courteney Cox as Kinerase(R) Spokesperson
Biopharmaceuticals Dermatology

HSMN NewsFeed - 16 Apr 2007
Integra LifeSciences Announces New Proposed Tracking Codes for Intracranial Monitoring
Devices Monitoring Reimbursement Neurosurgery

HSMN NewsFeed - 12 Apr 2007
FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA(R) (etoricoxib)
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Mar 2007
Protox Announces Senior Management Changes
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Mar 2007
Amira Pharmaceuticals Raises $25 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Mar 2007
Teva Provides Update on Generic Celebrex(R) Litigation
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 20 Mar 2007
Keppra(R) Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 15 Mar 2007
Medtronic Announces Initiation of U.S. Pivotal Trial to Evaluate the Cardioblate(R) Surgical Ablation System to Treat Permanent Atrial Fibrillation
Devices Cardiology

HSMN NewsFeed - 12 Mar 2007
New European Approval for Xyrem(R) Provides Significant Advance in the Treatment of Narcolepsy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Feb 2007
American Heart Association Scientific Statement: AHA Statement Recommends Doctors Change Approach to Prescribing Pain Relievers for Patients With or at Risk for Heart Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Feb 2007
Aspirin Significantly Reduces Esophageal-Cancer Risk in People With Most- Aggressive Form of Barrett's Esophagus
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Feb 2007
Nabi Biopharmaceuticals Announces Resignation of Thomas McLain as CEO and Appointment of Leslie Hudson as Interim CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2007
Schering-Plough Corporation Mourns Death of Bruce R. Reid, Leader in Pharmaceutical Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jan 2007
Zylera Pharmaceuticals Announces Availability of RELAMINE for the Treatment of Osteoarthritis
Biopharmaceuticals

HSMN NewsFeed - 22 Jan 2007
Plaintiff Drops VIOXX(R) Suit against Merck Five Weeks Before First Trial in Philadelphia State Court
Biopharmaceuticals Litigation

HSMN NewsFeed - 18 Jan 2007
Hospira Acquisition of Mayne Pharma Clears U.S. Antitrust Review
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Jan 2007
More European Patients With Epilepsy to Benefit From Keppra(R)
Biopharmaceuticals Regulatory Neurology

HSMN NewsFeed - 8 Jan 2007
Horizon Therapeutics Announces Special Protocol Assessment With FDA for Phase 3 Trial Program
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2007
ELAD(R) Bioartificial Liver Trial in China Achieves Significance at Halfway Point
Devices

HSMN NewsFeed - 4 Jan 2007
CryoCath Treats First Patients with New SurgiFrost(R) XL
Devices Cardiology

HSMN NewsFeed - 15 Dec 2006
Merck Wins Alabama VIOXX(R) Product Liability Case
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 Dec 2006
Merck Wins Federal VIOXX(R) Product Liability Case
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 Dec 2006
Breaking Study: Masimo Blue Sensor Proven Most Accurate in Measuring Oxygen Saturation on Babies With Cyanotic Heart Disease
Devices Monitoring

HSMN NewsFeed - 13 Dec 2006
Ambit Biosciences Announces Establishment of Clinical Oncology Advisory Board
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals

HSMN NewsFeed - 22 Nov 2006
Statement Regarding Dismissal of Personal Injury Class-Action Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 Nov 2006
Large Outcomes Study Showed Merck's ARCOXIA(R) (etoricoxib) had Similar Rates of Cardiovascular Thrombotic Events Compared to Diclofenac, the Most Prescribed Traditional NSAID Worldwide
Biopharmaceuticals

HSMN NewsFeed - 10 Nov 2006
Merck Responds to FDA-Issued Approvable Letters for Arcoxia(R) (etoricoxib)
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Nov 2006
NicOx receives FDA feedback that no cardiovascular outcomes study required for naproxcinod NDA
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Oct 2006
NicOx Naproxcinod Phase 3 OA Trial Meets Primary Endpoints and Shows Encouraging Blood Pressure Profile
Biopharmaceuticals

HSMN NewsFeed - 10 Oct 2006
DOV Pharmaceutical, Inc. Announces New Strategic Direction, Bicifadine Clinical Studies Results and Program Updates
Biopharmaceuticals

HSMN NewsFeed - 9 Oct 2006
Integra LifeSciences Announces Launch of the Mobius(TM) Multi Modality Monitoring System
Devices Neurosurgery Monitoring

HSMN NewsFeed - 2 Oct 2006
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
Biopharmaceuticals Orthopaedic Regulatory

HSMN NewsFeed - 2 Oct 2006
GTC Biotherapeutics and LFB Biotechnologies Enter Strategic Collaboration for Recombinant Plasma Proteins and Monoclonal Antibodies
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2006
Hospira Announces $2 Billion Agreement to Acquire Mayne Pharma
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Sep 2006
NEOPHARM Presents Updated CINTREDEKIN BESUDOTOX Phase I/II Median Survival Data at European Association of Neuro-Oncology (EANO) Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Jul 2006
Endovasc Cites Favorable Market Conditions for its Liprostin Drug
Biopharmaceuticals

HSMN NewsFeed - 13 Jul 2006
Merck Wins New Jersey VIOXX(R) Product Liability Case
Biopharmaceuticals Litigation

HSMN NewsFeed - 26 Jun 2006
New Data Published in an American Heart Association Journal Shows That Lipoprotein-Associated Phospholipase A2 Independently Adds to the Diagnostic Accuracy of Traditional Risk Assessment for Future Cardiovascular Events
Diagnostics Cardiology

HSMN NewsFeed - 23 Jun 2006
Positive Synvisc Data Presented at European Conference
Biopharmaceuticals

HSMN NewsFeed - 2 Jun 2006
ATryn(R) Receives CHMP Recommendation to Grant Market Authorization
Biopharmaceuticals Regulatory

HSMN NewsFeed - 30 May 2006
Merck Corrects Description of a Statistical Method Used in APPROVe Study
Biopharmaceuticals

HSMN NewsFeed - 24 May 2006
UCB Completes Mutual Recognition Procedure for Equasym(TM) XL
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 May 2006
Results of a Novel Investigational Asthma Treatment Reported at the American Thoracic Society Conference
Devices

HSMN NewsFeed - 15 May 2006
European Commission Approves Keppra(R) for Use as Adjunctive Therapy in the Treatment of Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 11 May 2006
Merck Announces Preliminary Analyses of Off-Drug Extension of APPROVe Study
Biopharmaceuticals Oncology Cardiology

Return to NewsFeed

Additional items found! 239

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 239 additional stories matching:
COX
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!